Fitness Cost of Antibiotic Resistance in Staphylococcus aureus: A Systematic Review
- PMID: 33417813
- DOI: 10.1089/mdr.2020.0426
Fitness Cost of Antibiotic Resistance in Staphylococcus aureus: A Systematic Review
Abstract
Background: Recent reports have shown the potential of Staphylococcus aureus for acquiring resistance to last-resort antibiotics. However, most antibiotic resistance mechanisms were associated with a fitness cost that was typically observed as a reduced bacterial growth rate. This systematic review aimed to address the fitness cost of antibiotic resistance in S. aureus that emerged by mutations. Methods: A systematic review was conducted after searching in two databases (PubMed and Scopus) using specific keywords. We included peer-reviewed articles published only in English. All studies describing the fitness cost associated with antibiotic resistance in S. aureus were selected. For each article, the results of fitness testing, minimum inhibition concentrations of mutants, the position of mutation, and the appearance of compensatory mutations were recorded. Results: At all, 35 articles were recorded in the final analysis examining the fitness cost associated with antibiotic resistance in S. aureus that conferred by mutations. Analysis of the data showed that 26 studies reported that the emergence of antibiotic resistance was frequently associated with a fitness cost. Conclusion: This review summarized that the antibiotic resistance selection caused in the majority of cases a substantial fitness cost. Further in vivo experiments revealed that these mutations affected bacterial virulence and the ability to establish a successful infection.
Keywords: Staphylococcus aureus; antibiotic resistance; compensatory mutations; fitness cost; mutation.
Similar articles
-
Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.BMC Microbiol. 2019 Sep 18;19(1):220. doi: 10.1186/s12866-019-1573-9. BMC Microbiol. 2019. PMID: 31533633 Free PMC article.
-
Fitness cost and compensatory evolution of penicillin-induced resistant Staphylococcus aureus.Food Res Int. 2025 Feb;203:115841. doi: 10.1016/j.foodres.2025.115841. Epub 2025 Jan 27. Food Res Int. 2025. PMID: 40022365
-
Comprehensive Genomic Investigation of Adaptive Mutations Driving the Low-Level Oxacillin Resistance Phenotype in Staphylococcus aureus.mBio. 2020 Dec 8;11(6):e02882-20. doi: 10.1128/mBio.02882-20. mBio. 2020. PMID: 33293382 Free PMC article.
-
Evolutionary Mechanisms Shaping the Maintenance of Antibiotic Resistance.Trends Microbiol. 2018 Aug;26(8):677-691. doi: 10.1016/j.tim.2018.01.005. Epub 2018 Feb 10. Trends Microbiol. 2018. PMID: 29439838 Review.
-
The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus.J Antimicrob Chemother. 2007 Jan;59(1):1-4. doi: 10.1093/jac/dkl429. Epub 2006 Oct 26. J Antimicrob Chemother. 2007. PMID: 17068009 Review.
Cited by
-
Fitness Burden for the Stepwise Acquisition of First- and Second-Line Antimicrobial Reduced-Susceptibility in High-Risk ESKAPE MRSA Superbugs.Antibiotics (Basel). 2025 Feb 28;14(3):244. doi: 10.3390/antibiotics14030244. Antibiotics (Basel). 2025. PMID: 40149055 Free PMC article.
-
Risk-Adapted Screening for Methicillin-Resistant Staphylococcus aureus.Dtsch Arztebl Int. 2023 Jun 30;120(26):445-446. doi: 10.3238/arztebl.m2023.0131. Dtsch Arztebl Int. 2023. PMID: 37594462 Free PMC article. No abstract available.
-
Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives.Molecules. 2025 Apr 29;30(9):1983. doi: 10.3390/molecules30091983. Molecules. 2025. PMID: 40363790 Free PMC article.
-
Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition.Antibiotics (Basel). 2021 Dec 7;10(12):1502. doi: 10.3390/antibiotics10121502. Antibiotics (Basel). 2021. PMID: 34943714 Free PMC article. Review.
-
Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability.PLoS Pathog. 2024 Aug 29;20(8):e1012422. doi: 10.1371/journal.ppat.1012422. eCollection 2024 Aug. PLoS Pathog. 2024. PMID: 39207957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical